Medicus Pharma Ltd. (MDCXW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Medicus Pharma Ltd.

    NASDAQ: MDCXW · Real-Time Price · USD
    0.80
    0.02 (2.56%)
    At close: Sep 26, 2025, 12:44 PM

    Medicus Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -10.64M -4.82M -978.42K -1.44M
    Interest Income
    		 24.17K n/a n/a n/a
    Pretax Income
    		 -11.16M -5.41M -1.69M -2.06M
    Net Income
    		 -10.62M -5.41M -1.69M -2.06M
    Selling & General & Admin
    		 7.29M 4.62M 332.03K 258.01K
    Research & Development
    		 3.36M 197.13K 646.38K 1.18M
    Other Expenses
    		 536.84K n/a n/a n/a
    Operating Expenses
    		 11.18M 4.82M 978.42K 1.44M
    Interest Expense
    		 902.36K 595.54K 526.83K 115.41K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 11.18M -4.82M 978.42K 1.44M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 11.82M 8.08M n/a n/a
    Shares Outstanding (Diluted)
    		 11.82M 8.08M n/a n/a
    EPS (Basic)
    		 -0.9 -0.67 n/a n/a
    EPS (Diluted)
    		 -0.9 -0.67 n/a n/a
    EBITDA
    		 -10.62M -4.82M -1.17M -1.94M
    EBIT
    		 -10.62M -4.82M -1.17M -1.94M
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist